Analysis of National Lab Database to evaluate the HIV treatment rollout in South Africa
By linking lab tests on detailed patient identifiers, a national, patient-level longitudinal cohort is being developed, which contains over 3 million ART initiators and over 23 million observations. This “NHLS Patient Cohort” will enable us to evaluate the national ART program using data that are nationally representative and robust to self-transfer across care settings. Through a partnership between Wits University in South Africa and Boston University in the U.S., this project will address each of the following specific aims, using the NHLS Patient Cohort:
- Quantify the effect of the national HIV testing campaign on uptake of HIV care and treatment
- Estimate national retention rates in pre-ART care and post-ART initiation
- Establish long run treatment outcomes for a national patient cohort
- Estimate the effects of immediate vs. deferred ART eligibility on retention and clinical outcomes
Publications
The following publications emanate from this project:
-
Delays in repeat HIV viral load testing for those with elevated viral loads: A national perspective from South Africa
-
SOUTH AFRICA’s 2010 NATIONAL HIV TESTING CAMPAIGN AND NUMBERS ENROLLING IN CARE
-
USING PRIVATE MEDICAL SCHEME DATA TO ESTIMATE SOUTH AFRICA’S HIV CARE AND TREATMENT BURDEN BY GEOGRAPHIC AREA
-
Acceptability and feasibility of a financial incentive intervention to improve retention in HIV care among pregnant women in Johannesburg, South Africa
-
Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa
Funded by
HE2RO staff involved
Dr Mhairi Maskew Dr. William Macleod Cheryl Hendrickson Cornelius Nattey Dr. Lise Jamieson Ross GreenerStay up to date
Receive newsletters and keep up to date with developments at HE2RO.